BishtRef
Articles Journals Publishers Authors Subjects Most Cited New Papers Year Stats Open Access
journal article Apr 01, 2003

Insulin and Carbohydrate Dysregulation

Marie C. Gelato
Clinical Infectious Diseases Vol. 36 No. s2 pp. S91-S95 · Oxford University Press (OUP)
View at Publisher Save 10.1086/367564
Topics

No keywords indexed for this article. Browse by subject →

References
42
[1]
Lumpkin MM. Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV). FDA Public Health Advisory 1997.
[4]
Ekong E, Uwah A, Akanmu A. Prevalence of lipodystrophy syndrome in a cohort of patients exposed to anti-retroviral drug therapy [abstract 016]. In: Program and abstracts of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (Toronto). 2000:11.
[7]
Keruly JC, Chaisson RE, Moore RD. Diabetes and hyperglycemia in patients receiving protease inhibitors [abstract]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections (Chicago). 1998.
[10]
Dube MP Antivir Ther (2000)
[16]
Haffner SM Diabetes Care (1999) 10.2337/diacare.22.4.562
[17]
Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

Kathleen Mulligan, Carl Grunfeld, Viva W. Tai et al.

JAIDS Journal of Acquired Immune Deficiency Syndro... 2000 10.1097/00126334-200001010-00005
[21]
Flier SJ Philadelphia: JB Lippincott (1990)
[22]
Ledru E Blood (2000) 10.1182/blood.v95.10.3191
[23]
Gervasoni C, Ridolfo A, Riva A, Santambrogio S, Clerici M, Galli M. Adiposity and lower limb wasting in women under ART are not associated with an increase of TNF-alpha production [abstract P27]. In: Program and abstracts of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (Toronto). 2000:39.
[24]
Hotamisligil GS J Clin Invest (1995) 10.1172/jci117936
[28]
American Diabetes Association Diabetes Care (2000)
[29]
Philadelphia: WB Saunders (1997)
[34]
Walli RK, Michl GM, Bogner JR, Goebel FD. Effects of the PPAR-activator troglitazone on protease inhibitor associated peripheral insulin resistance. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections (Chicago, January 31-February 4, 1999). 1999.
[35]
Gelato MC J Acquir Immune Defic Syndr (2002) 10.1097/00126334-200210010-00006
[36]
Sutinen J, Hakkinen AM, Westerbacka J, etal Rosiglitazone in the treatment of HAART associated lipodystrophy (HAL): a randomized, double-blind, placebo-controlled study [abstract LB13]. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). 2002. 10.1177/135965350300800303
[38]
Tebas P, Yarasheski K, Powderly WG, etal A prospective, open-label pilot trial of a maintenance nevirapine-containing regimen in patients with undetectable viral loads on protease inhibitor regimens for at least 6 months [abstract 45]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco, January 30-February 2, 2000). 2000.
[39]
Carr A, Thorisdottir A, Samaras K, Kaufman GR, Chisholm DJ, Cooper DA. Reversibility of protease inhibitor (PI) lipodystrophy syndrome on stopping PIs or switching to nelfinavir [abstract 668]. In: Program and abstracts of the 6th Congress on Retroviruses and Opportunistic Infections (Chicago). 1999. 10.1016/s0140-6736(98)08468-2
[40]
Powderly WG. Lessons learned from switching antiretrovirals [abstract 027]. In: Program and abstracts of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (Toronto). 2000:17.
[41]
Goebel F, Walli RK. A novel use of abacavir to simplify therapy in PI experienced patients successfully treated with HAART: CNA30017 [abstract]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). 2000.
Metrics
25
Citations
42
References
Details
Published
Apr 01, 2003
Vol/Issue
36(s2)
Pages
S91-S95
Authors
M
Marie C. Gelato
Cite This Article
Marie C. Gelato (2003). Insulin and Carbohydrate Dysregulation. Clinical Infectious Diseases, 36(s2), S91-S95. https://doi.org/10.1086/367564
Related

You May Also Like

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

H. Wisplinghoff, T. Bischoff · 2004

3,528 citations

Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis

J. S. Li, D. J. Sexton · 2000

3,312 citations

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Peter G. Pappas, Carol A. Kauffman · 2015

2,867 citations

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Andre C. Kalil, Mark L. Metersky · 2016

2,773 citations

State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men

William A. Craig · 1998

2,457 citations